vimarsana.com

Latest Breaking News On - Prnewswire alpheus - Page 1 : vimarsana.com

Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment

Milestone arrives as the company closes a $14 million follow-on Series A financing round to expand the clinical program for high-grade gliomas, in.

New yorkUnited statesCarla benigniVijay agarwalPrnewswire alpheusMichael schulderTannerm johannsMedtech convergence fundSv health investorsBrain tumor investment fundNorthwell health north shore university hospitalDent neurologic institute buffaloAlpheus medical incNational brain tumor societyWashington university in stAmerican cancer society

Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer

/PRNewswire/ Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today.

United statesVijay agarwalPaulc bucyRoger stuppDavid reardonPrnewswire alpheusWalter stummerGerman society for neurosurgeryDepartment of neurologyDavid reardon harvard medical schoolChemistry at trinity college dublinOncology at dana farber cancer instituteDana farber cancer instituteWalter stummer university hospital muMathias senge trinity college dublinScientific advisory board

Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer

/PRNewswire/ Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today.

United statesVijay agarwalPaulc bucyRoger stuppDavid reardonPrnewswire alpheusWalter stummerGerman society for neurosurgeryDepartment of neurologyDavid reardon harvard medical schoolChemistry at trinity college dublinOncology at dana farber cancer instituteDana farber cancer instituteWalter stummer university hospital muMathias senge trinity college dublinScientific advisory board

vimarsana © 2020. All Rights Reserved.